Pharmacovigilance in Juvenile Idiopathic Arthritis Patients (Pharmachild) Treated With Biologic Agents and/or Methotrexate. Consolidated Baseline Characteristics From Pharmachild and Other National Registries

Pediatric Rheumatology - United Kingdom
doi 10.1186/1546-0096-12-s1-p7

Related search